Thursday, October 13, 2011

Nature Biotechnology Contents: Volume 29 pp 849 - 950

Nature Biotechnology

New patent pending CO2/O2 Gas Control Module (GCM™)

Infinite 200PRO with GCM is a breakthrough for cell-experiments

• Consistent physiological conditions
• Predictable culture growth
• No transport of cell cultures from incubator to reader
• Complete data sets overnight

Learn more
TABLE OF CONTENTS

October 2011 Volume 29, Issue 10

In This Issue
Editorial
News
News Feature
Bioentrepreneur
Opinion and Comment
Features
News and Views
Research Highlights
Computational Biology
Research
Careers and Recruitment

Advertisement

TALEN® Access: new affordable genome customization tools

Our recently launched and very affordable TALEN® Access service offer includes the production of a Custom TAL Effector Nuclease (TALEN®) targeting any gene. TALENs® are next generation genome customization tools to knock-out genes or introduce modifications in any gene, at any position. More >>


recommend to your libraryRecommend to your library
live newsfeedsWeb feed
Content is available online onlyAvailable online only
subscribeSubscribe
Advertisement
ONLINE Graduate Programs in Biopharmaceutical Leadership
Emmanuel College's online Graduate Certificate in Biopharmaceutical Leadership is a one-year part-time program for scientists working in the research environment. It is taught by industry experts and addresses critical skills in management and business in the biopharmaceutical industry.
Enroll Now for Spring 2012!
Naturejobs

 
Advertisement

BIOPHARMA DEALMAKERS
BIOPHARMA DEALMAKERSCompany Profiles and Partnering Opportunities


 
Advertisement
JOHNS HOPKINS UNIVERSITY - ONLINE INFORMATION SESSIONS
Earn your MASTER'S degree FULLY ONLINE with JHU's Advanced Biotechnology Studies programs. Attend an ONLINE Info Session for - Biotechnology Enterprise & Entrepreneurship (10/12), Biotechnology (10/13), Bioscience Regulatory Affairs & Enterprise (10/18), Bioinformatics (10/20). Learn more and RSVP online at biotechnology.jhu.edu.
 
Advertisement

BioPharma Dealmakers
Science, strategy & innovation

Recent content exclusively made freely available to you from
Nature Biotechnology, Nature Reviews Drug Discovery and Nature Medicine
Produced with support from TVG

Sign up to receive this new bi-weekly newsletter today.

 

In This Issue

Top

In this issue ppvii - viii
doi:10.1038/nbt.2010
Full Text | PDF

Editorial

Top

Enlightened engineering p849
doi:10.1038/nbt.2016
Optogenetics—until now primarily a tool for asking questions in basic research—is starting to spur efforts oriented toward biomedical applications.
Full Text | PDF

News

Top

Seattle Genetics rare cancer drug sails through accelerated approval pp851 - 852
Laura DeFrancesco
doi:10.1038/nbt1011-851
Full Text | PDF

HIV drugs made in tobacco p852
Jeffrey L Fox
doi:10.1038/nbt1011-852
Full Text | PDF

Engineered T-cell therapy shows efficacy in blood cancer pp853 - 855
Simon Frantz
doi:10.1038/nbt1011-853
Full Text | PDF

9,000 tumors for stratified medicine p854
Susan Aldridge
doi:10.1038/nbt1011-854a
Full Text | PDF

Chinese inventors catch up p854
Nuala Moran
doi:10.1038/nbt1011-854b
Full Text | PDF

ATM cash for biotechs p856
Brian Orelli
doi:10.1038/nbt1011-856a
Full Text | PDF

Pertuzumab to bolster Roche/Genentech's breast cancer franchise? pp856 - 858
Cormac Sheridan
doi:10.1038/nbt1011-856b
Full Text | PDF

Gilead donates patents for generics p857
Simon Frantz
doi:10.1038/nbt1011-857a
Full Text | PDF

South Korea's stem cell approval p857
Heiko Yang
doi:10.1038/nbt1011-857b
Full Text | PDF

Data Page

Drug pipeline: Q311 p859
Wayne Peng
doi:10.1038/nbt.1999
Full Text | PDF

News Feature

Top

Attacks on asthma pp860 - 863
Sarah Webb
doi:10.1038/nbt.1994
The current standard of care for asthma leaves large numbers of sufferers at risk for severe exacerbations and even death. But emerging targeted therapies that may provide better treatment options also face obstacles. Sarah Webb reports.
Full Text | PDF

Advertisement
Off-axis StepWave™ ion transfer technology, now integrated in the SYNAPT® G2-S Mass Spectrometry System from Waters, provides a significant increase in sensitivity in all available data acquisition modes.
Learn More

SYNAPT G2-S from Waters provides scientists with a UPLC/HDMSE solution with an easy-to-use and highly specific lipid analysis method that delivers robust and reproducible results.
Click Here To Learn More

Bioentrepreneur

Top
Building a business

Headwinds into opportunity pp864 - 866
Prabhavathi Fernandes
doi:10.1038/bioe.2011.8
Full Text | PDF

Opinion and Comment

Top
Correspondence

A methodological framework to enhance the clinical success of cancer immunotherapy pp867 - 870
Axel Hoos, Cedrik M Britten, Christoph Huber and Jill O'Donnell-Tormey
doi:10.1038/nbt.2000
Full Text | PDF

Pharmacogenetics and the immunogenicity of protein therapeutics pp870 - 873
Chen Yanover, Nisha Jain, Glenn Pierce, Tom E Howard and Zuben E Sauna
doi:10.1038/nbt.2002
Full Text | PDF

Wanted: bioprospecting consultants pp873 - 875
Kazuo N Watanabe and Guat Hong Teh
doi:10.1038/nbt.2001
Full Text | PDF

Features

Top
Patents

Evergreening: a common practice to protect new drugs pp876 - 878
Kate S Gaudry
doi:10.1038/nbt.1993
The common strategy of evergreening using patents and other exclusivity periods likely contributes to the total incentives that justify a pharmaceutical company's investment in a new drug.
Full Text | PDF

Recent patent applications in drug screening p879
doi:10.1038/nbt.2007
Full Text | PDF

Advertisement
Exclusive discounts are now available online

Nature Lab Offers provides researchers like you with exclusive discounts on products used in your lab. Browse through US Offers or Global Offers on antibodies, cell culture, PCR, software, pipettors, reagents, and more!

US Offers Global Offers

News and Views

Top

New fluorescent probes for super-resolution imaging pp880 - 881
Joshua C Vaughan and Xiaowei Zhuang
doi:10.1038/nbt.1997
Fatigue-resistant, photoswitchable fluorescent proteins facilitate sub-diffraction-limit imaging of living cells with low light intensity.
Full Text | PDF
See also: Research by Brakemann et al.

Tracking down the human myelinating cell pp881 - 883
Robert H Miller and Paul J Tesar
doi:10.1038/nbt.2004
A new strategy for isolating oligodendrocyte progenitor cells from the human brain may advance the goal of therapeutic remyelination.
Full Text | PDF
See also: Research by Sim et al.

RNA lights up pp883 - 884
John S Mattick and Michael B Clark
doi:10.1038/nbt.2003
A new method to genetically tag RNA for fluorescence imaging in live cells simplifies imaging of cellular RNAs.
Full Text | PDF

Biotechnology
JOBS of the week
Postdoctoral Research Associate
University of Innsbruck, Austria
Innsbruck, AT
Postdoctoral fellows in Computational Genomics and Stem Cell / Epigenetics
Tsinghua University, Beijing, China
Beijing, CN
Group Leader – Protein Purification Development
Hudson Shribman Scientific Recruitment
GB
Group Leader Position
Research Institute of Molecular Pathology
Vienna, AT
Research Opportunities
French Alternative Energies and Atomic Energy Commission
Gif Sur Yvette, FR
More Science jobs from
Biotechnology
EVENT
Lyophilization Technology – Practical Application of the Scientific Principles
October 17-19, 2011
PA, US
More science events from

Research Highlights

Top

Cancer stem cells predict patient survival | FcγRIIb engagement kills tumors | Arming yeast for synthetic biology | Broad-spectrum antiviral strategy | Motor neurons to order


Computational Biology

Top
Analysis

Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE pp886 - 891
Peng Qiu, Erin F Simonds, Sean C Bendall, Kenneth D Gibbs Jr, Robert V Bruggner, Michael D Linderman, Karen Sachs, Garry P Nolan and Sylvia K Plevritis
doi:10.1038/nbt.1991
New instruments can measure the presence of >30 molecular markers for massive numbers of single cells, but data analysis algorithms have lagged behind. Qiu et al. describe an approach called SPADE for recovering cellular hierarchies from mass or flow cytometry data.
Abstract | Full Text | PDF

Research

Top
Review

Direct lineage conversions: unnatural but useful? pp892 - 907
Thomas Vierbuchen and Marius Wernig
doi:10.1038/nbt.1946
Abstract | Full Text | PDF

Analysis

Performance comparison of exome DNA sequencing technologies pp908 - 914
Michael J Clark, Rui Chen, Hugo Y K Lam, Konrad J Karczewski, Rong Chen, Ghia Euskirchen, Atul J Butte and Michael Snyder
doi:10.1038/nbt.1975
Capturing and sequencing only the coding regions of the human genome leverages resources in the pursuit of rare disease-causing mutations. Clark et al. compare the performance of three leading exome-capture methods and their advantages over whole-genome sequencing.
Abstract | Full Text | PDF

Articles

Efficient de novo assembly of single-cell bacterial genomes from short-read data sets pp915 - 921
Hamidreza Chitsaz, Joyclyn L Yee-Greenbaum, Glenn Tesler, Mary-Jane Lombardo, Christopher L Dupont, Jonathan H Badger, Mark Novotny, Douglas B Rusch, Louise J Fraser, Niall A Gormley, Ole Schulz-Trieglaff, Geoffrey P Smith, Dirk J Evers, Pavel A Pevzner and Roger S Lasken
doi:10.1038/nbt.1966
DNA can be amplified and sequenced from a single cell, but unevenness of the sequence coverage complicates efforts to assemble a high-quality genome. Chitsaz et al. devise an algorithm to address this problem and apply it to assemble a genome draft of an uncultured single-cell marine organism from one lane of Illumina sequence data.
Abstract | Full Text | PDF

Comparative genomic analysis of the thermophilic biomass-degrading fungi Myceliophthora thermophila and Thielavia terrestris  pp922 - 927
Randy M Berka, Igor V Grigoriev, Robert Otillar, Asaf Salamov, Jane Grimwood, Ian Reid, Nadeeza Ishmael, Tricia John, Corinne Darmond, Marie-Claude Moisan, Bernard Henrissat, Pedro M Coutinho, Vincent Lombard, Donald O Natvig, Erika Lindquist, Jeremy Schmutz, Susan Lucas, Paul Harris, Justin Powlowski, Annie Bellemare, David Taylor, Gregory Butler, Ronald P de Vries, Iris E Allijn, Joost van den Brink, Sophia Ushinsky, Reginald Storms, Amy J Powell, Ian T Paulsen, Liam D H Elbourne, Scott E Baker, Jon Magnuson, Sylvie LaBoissiere, A John Clutterbuck, Diego Martinez, Mark Wogulis, Alfredo Lopez de Leon, Michael W Rey and Adrian Tsang
doi:10.1038/nbt.1976
Thermostable enzymes are used for a range of industrial processes, including biofuel production. Berka et al. report the genome sequences of two thermophilic eukaryotic fungi with enzymes that operate at the elevated temperatures needed to digest biomass and prepare many biochemicals.
Abstract | Full Text | PDF

Tracking single hematopoietic stem cells in vivo using high-throughput sequencing in conjunction with viral genetic barcoding pp928 - 933
Rong Lu, Norma F Neff, Stephen R Quake and Irving L Weissman
doi:10.1038/nbt.1977
Heterogeneity within populations of stem cells, cancer cells or other cell types of interest presents a formidable barrier to analysis. Lu et al. use viral barcoding and high-throughput sequencing to track the differentiation of single hematopoietic stem cells in vivo.
Abstract | Full Text | PDF

CD140a identifies a population of highly myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cells pp934 - 941
Fraser J Sim, Crystal R McClain, Steven J Schanz, Tricia L Protack, Martha S Windrem and Steven A Goldman
doi:10.1038/nbt.1972
Oligodendrocyte progenitors capable of myelination in myelin-deficient mice have been isolated from human fetal brain cells, but at low purity. Sim et al. show that sorting based on PDGFR[alpha] expression yields a purer population of myelinogenic cells free of neuronal and committed astrocyte cells.
Abstract | Full Text | PDF
See also: News and Views by Miller & Tesar

A reversibly photoswitchable GFP-like protein with fluorescence excitation decoupled from switching pp942 - 947
Tanja Brakemann, Andre C Stiel, Gert Weber, Martin Andresen, Ilaria Testa, Tim Grotjohann, Marcel Leutenegger, Uwe Plessmann, Henning Urlaub, Christian Eggeling, Markus C Wahl, Stefan W Hell and Stefan Jakobs
doi:10.1038/nbt.1952
Brakemann et al. present a reversibly photoswitchable fluorescent protein, called Dreiklang, that can be turned on and off at wavelengths distinct from those used for imaging. They show that the protein is advantageous for studying protein dynamics in living cells and for super-resolution imaging.
Abstract | Full Text | PDF
See also: News and Views by Vaughan & Zhuang

Careers and Recruitment

Top

A global need for women's biotech leadership pp948 - 949
Laurel Smith-Doerr, Gintare Kemekliene, Rita Teutonico, Lene Lange, Lydia Villa-Komaroff, Line Matthiessen-Guyader and Fiona Murray
doi:10.1038/nbt.1998
Increasing women's participation in leadership of biotech policy making, funding, research and implementation will strengthen the race to solve global problems.
Full Text | PDF

People

People p950
doi:10.1038/nbt.2006
Full Text | PDF

Top
Advertisement
Nature Reprint Collection
The future of drug innovation

This special reprint collection provides a comprehensive overview of the factors underlying the challenges in drug innovation and the evolution of possible scientific and strategic solutions.

Access the Collection by visiting:
www.nature.com/reprintcollections/lilly/drug-innovation

Produced with support from:
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant)

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our customer feedback department

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: